Suchergebnisse - "Motoi, Noriko"

PubPharm (9)

1

Pulmonary microinvasive small cell carcinoma with an extensive in-situ component identified after photodynamic therapy for 'squamous cell carcinoma in situ' : a case report

enthalten in: Histopathology | 2021

von Ota, M. | Nakatani, Y. | Nakajima, T. | +4

2

Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Shirasawa, M. | Yoshida, T. | Matsumoto, Y. | +8

3

Trimodality therapy for superior sulcus tumour : experience of a single institution over 19 years

enthalten in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery | 2019

von Uchida, S. | Yoshida, Y. | Ohe, Y. | +6

4

Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Sekine, K. | Kanda, S. | Goto, Y. | +5

5

Actinin-4 protein overexpression as a predictive biomarker in adjuvant chemotherapy for resected lung adenocarcinoma

enthalten in: Biomarkers in medicine | 2017

von Shiraishi, H. | Fujiwara, Y. | Kakuya, T. | +12

6

Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2016

von Horiike, A. | Takeuchi, K. | Uenami, T. | +11

7

P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

enthalten in: EBioMedicine | 2016

von Katayama, R. | Sakashita, T. | Yanagitani, N. | +19

8

Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study

enthalten in: Japanese journal of clinical oncology | 2015

von Nakano, K. | Motoi, N. | Inagaki, L. | +7

9

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2007

von Bean, J. | Brennan, C. | Shih, J. | +20

1
[1]